Alumis (ALMS) Non-Current Assets (2023 - 2026)
Alumis (ALMS) posted quarterly Non-Current Assets of $93.7 million for Q4 2025, up 169.24% year-over-year from $34.8 million in Q4 2024, and down 1.07% quarter-over-quarter from $94.7 million in Q3 2025.
Alumis (ALMS) Non-Current Assets (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Non-Current Assets for 3 consecutive years, with $93.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Assets rose 169.24% year-over-year to $93.7 million; the TTM figure through Dec 2025 stood at $317.6 million (up 116.63% YoY), while the FY2025 annual figure was $93.7 million, up 169.24% from the prior year.
- Non-Current Assets slipped to $93.7 million in Q4 2025 per ALMS's latest filing, from $94.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $94.7 million in Q3 2025 and bottomed at $34.8 million in Q4 2024.
- Historically, Non-Current Assets has averaged $58.0 million across 3 years, with a median of $38.3 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Assets dropped 4.0% — and 2025, when it jumped 169.24%.
- Alumis' Non-Current Assets stood at $36.3 million in 2023, then slipped by 4.0% to $34.8 million in 2024, then surged by 169.24% to $93.7 million in 2025.
- Business Quant data shows ALMS's Non-Current Assets at $93.7 million in Q4 2025, $94.7 million in Q3 2025, and $93.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | 46.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.53 Mn |
| Dec 31, 2025 | 93.71 Mn |
| Sep 30, 2025 | 94.72 Mn |
| Jun 30, 2025 | 93.37 Mn |
| Mar 31, 2025 | 35.77 Mn |
| Dec 31, 2024 | 34.80 Mn |
| Sep 30, 2024 | 35.21 Mn |
| Jun 30, 2024 | 40.32 Mn |
| Dec 31, 2023 | 36.26 Mn |